Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;81(1):30-4.
doi: 10.1016/j.contraception.2009.07.007.

Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception

Mags E Beksinska  1 , Jenni A Smit, Immo Kleinschmidt, Cecilia Milford, Timothy M M Farley
Affiliations

Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception

Mags E Beksinska et al. Contraception. 2010 Jan.

Abstract

Background: Weight gain is commonly reported as a side effect of hormonal contraception and can lead to method discontinuation or reluctance to initiate the method. The purpose of this study was to investigate weight change in adolescent (aged 15-19 years) users of depot-medroxyprogesterone acetate (DMPA), norethisterone enanthate (NET-EN), combined oral contraceptives (COCs) and discontinuers of these methods as compared to nonusers of hormonal contraception.

Study design: This longitudinal study recruited initiators of DMPA (n=115), NET-EN (n=115), COCs (n=116) and nonusers of contraception (n=144). Participants were followed up for 4-5 years, and details of current contraceptive method, including switching, discontinuing and/or starting hormonal methods were documented at each 6-monthly visit. Women were classified according to their contraceptive histories on completion of the study, and injectable users were combined into one group for analysis. Height, weight and self-reported dieting were recorded at each visit.

Results: There was no difference in mean age or weight between the groups at baseline. Women using DMPA or NET-EN throughout, or switching between the two, had gained an average of 6.2 kg compared to average increases of 2.3 kg in the COC group, 2.8 kg in nonusers and 2.8 kg among discontinued users of any method (p=.02). There was no evidence of a difference in weight gain between women classified as nonobese or classified as overweight/obese in any of the four study groups at baseline.

Conclusion: There is fairly strong evidence that adolescent contraceptive hormonal injectable users appear to gain more weight than COC users, discontinuers and nonusers of contraception.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participant contraceptive history per study group
See this image and copyright information in PMC

References

    1. World Health Organization Special Programme of Research, Development and Research Training in Human Reproductive Task Force on Long-acting Systemic Agents for the Regulation of Fertility Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: Norethisterone enanthate given in two dosage regimens and depot medroxyprogesterone acetate: Final report. Contraception. 1983;23:1–20.
    1. Harel Z, Biro FM, Kollar LM, Rauh JL. Adolescents reasons for and experience after discontinuation of the long-acting contraceptive Depo-Provera and Norplant. J Adolesc health. 1996;19(2):118–23. - PubMed
    1. Gupta S. Weight gain on the combined pill--is it real? Human Reproduction Update. 2000;6(5):427–431. - PubMed
    1. Howard G, Blair M, Fotherby K, Elder MG, Bye P. Seven years clinical experience of the injectable contraceptive, norethisterone oenanthate. Br J Fam Plann. 1985;11:9–16.
    1. Bahamondes L, Del Castillo S, Tabares G, Arce XE, Perrotti M, Petta C. Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years. Contraception. 2001;64:223–5. - PubMed

Publication types

MeSH terms